ANALISIS LOSS OF HETEROZYGOSITYGEN RAR β2 PADA PATOGENESIS KANKER PAYUDARA
Abstract
References
Deng G, Luy Zionikov G dan AD Smith AS. Loss of heterozygosity a normal tissue adjacert to breast carcinoma. Science, 1995; 274:2057-2059
Cotran, Robbins, R.L. dan Kumar, V. 1989, Pathology Basic of Disease: Breast Cancer, 4thedition, WB Saunders International Edition, Four Edition, 1989; 192-200.
Evans TRJ, Kayes. B. Retinoids present role and future BRJ Cancer. 1999;80:1-6.
Khramer, Digiovanna JJ, Peck GL. Chemoprevention of skin cancer xerodermal pigmentosom, J. Dermato. 1992, 1987; 715 – 718.
Lippman SM, lee JJ, Sabichi Al. Cancer chemoprevention progress and promise. J. Nati Cancer inst; 1998 ;85:1492 – 1498.
Liu X, Lee Mo, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JL, Zhang X. Retinoic acid by promoting apoptosis human breast cancer cells. Mo Cell Biol, 1996;6:1188 – 1149
Sirchia SM, Ferguson AT, Sironi E, Subramayan S, Orlandi R, Sukumar S, Sacchi N. evidence of epigenetic changes attecting the chromatin state
of the retinoic acid receptor beta 2 promoter n breast cancer cell oncogene. 2000;19:1556 – 1563
Gote S, sinrett D, Momparier RL. Demethylation by 5-aza 2 deoxy cytidine at specific 5-methylcytosine s les in the promoter region on the
retinoid acid receptor beta gene in human colon carcinoma cell antitumor drugs.19989:743 – 750
Kane MF, Loda M, Gaida GM Lipmann J, Mishra, Goldman – fassud JM Kolodner R. Methylation of the aMLH promoter correlated with lack of
expression of VLH a sporadic colon tumor and stomach detective human tumor cell cancer. res 1997; 57: 5556-5560
Knazer K, Vogeisteir B. Lesson from hereditary colorectal cancer cel.1996;87:159-192
Berard J, Laboune F, Mukuna M, Masse S, Khotary R, Bradey WE. Lung tumors in mice expressing an antisense RAR β2.Transgene Faseb. 1996; 10 - 09 – 1097.
DOI: http://dx.doi.org/10.21776/ub.jkb.2008.024.02.5
Refbacks
- There are currently no refbacks.